StonvexLoading…
StonvexCore line items from DGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.04B | $9.87B | $9.25B | $9.88B |
Operating Income | $1.56B | $1.35B | $1.26B | $1.43B |
Net Income | $992.00M | $871.00M | $854.00M | $946.00M |
EPS (Diluted) | $8.75 | $7.69 | $7.49 | $7.97 |
Total Assets | $16.23B | $16.15B | $14.02B | $12.84B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $420.00M | $549.00M | $686.00M | $315.00M |
Free Cash Flow OCF − CapEx | $1.36B | $909.00M | $864.00M | $1.31B |
Shares Outstanding | 113.00M | 113.00M | 113.00M | 118.00M |